Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

283 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score.
Barber PA, Demchuk AM, Zhang J, Buchan AM. Barber PA, et al. Lancet. 2000 May 13;355(9216):1670-4. doi: 10.1016/s0140-6736(00)02237-6. Lancet. 2000. PMID: 10905241
Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.
Buchan AM, Barber PA, Newcommon N, Karbalai HG, Demchuk AM, Hoyte KM, Klein GM, Feasby TE. Buchan AM, et al. Neurology. 2000 Feb 8;54(3):679-84. doi: 10.1212/wnl.54.3.679. Neurology. 2000. PMID: 10680803
OBJECTIVE: To examine whether the demonstrated efficacy of tissue-type plasminogen activator (t-PA) for acute ischemic stroke can be effective in a community setting. METHODS: Sixty-eight consecutive patients with acute ischemic stroke treated with IV t-PA within 3 …
OBJECTIVE: To examine whether the demonstrated efficacy of tissue-type plasminogen activator (t-PA) for acute ischemic stroke can be …
Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.
Hill MD, Barber PA, Takahashi J, Demchuk AM, Feasby TE, Buchan AM. Hill MD, et al. CMAJ. 2000 May 2;162(9):1281-4. CMAJ. 2000. PMID: 10813008 Free PMC article.
Among 105 patients given recombinant tissue plasminogen activator (rt-PA, alteplase) intravenously for acute stroke, 2 (1.9%) had lingual angioedema, which progressed to a fatal anaphylactoid reaction in 1. ...
Among 105 patients given recombinant tissue plasminogen activator (rt-PA, alteplase) intravenously for acute stroke, 2 (1.9%) had lin …
Doubts, fears and misconceptions. What is the future of thrombolysis in acute stroke?
Barber PA, Hill MD, Demchuk AM, Buchan AM. Barber PA, et al. Can J Neurol Sci. 2000 Nov;27(4):283-7. doi: 10.1017/s0317167100001001. Can J Neurol Sci. 2000. PMID: 11097516 Review.
Thrombolysis in brain ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator.
Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, Alexandrov AV. Demchuk AM, et al. Stroke. 2001 Jan;32(1):89-93. doi: 10.1161/01.str.32.1.89. Stroke. 2001. PMID: 11136920 Clinical Trial.
Symptomatic hemorrhage after alteplase therapy not due to silent ischemia.
Hill MD, Barber PA, Demchuk AM, Sevick RJ, Frayne R, Buchan AM. Hill MD, et al. BMC Neurol. 2001 Dec 18;1:1. doi: 10.1186/1471-2377-1-1. Epub 2001 Dec 18. BMC Neurol. 2001. PMID: 11208259 Free PMC article.
Understanding and managing ischemic stroke.
Barber PA, Auer RN, Buchan AM, Sutherland GR. Barber PA, et al. Can J Physiol Pharmacol. 2001 Mar;79(3):283-96. Can J Physiol Pharmacol. 2001. PMID: 11294605 Review.
A three-item scale for the early prediction of stroke recovery.
Baird AE, Dambrosia J, Janket S, Eichbaum Q, Chaves C, Silver B, Barber PA, Parsons M, Darby D, Davis S, Caplan LR, Edelman RE, Warach S. Baird AE, et al. Lancet. 2001 Jun 30;357(9274):2095-9. doi: 10.1016/s0140-6736(00)05183-7. Lancet. 2001. PMID: 11445104
283 results
Jump to page
Feedback